Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $679.94 billion, securing the top spot among global Biotech companies. Johnson & Johnson (JNJ) and AbbVie (ABBV) follow closely behind. The data was last updated on April 16, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
1
|
 Eli Lilly
LLY
|
$679.94 B | $757.18 |
-7.9%
|
1.5%
|
United States
|
|
2
|
 Johnson & Johnson
JNJ
|
$370.20 B | $153.62 |
-6.5%
|
9.5%
|
United States
|
|
3
|
 AbbVie
ABBV
|
$312.76 B | $176.80 |
-17.3%
|
10.5%
|
United States
|
|
4
|
 Novo Nordisk
NVO
|
$286.98 B | $64.49 |
0.00%
|
-37.2%
|
Denmark
|
|
5
|
 Novo Nordisk A/S
NOVO-B.CO
|
$284.62 B | $64.12 |
0.00%
|
-33.1%
|
Denmark
|
|
6
|
 Roche
ROG.SW
|
$247.41 B | $308.66 |
0.00%
|
33.4%
|
Switzerland
|
|
7
|
 Novartis
NVS
|
$217.12 B | $109.93 |
0.00%
|
13.3%
|
Switzerland
|
|
8
|
 AstraZeneca
AZN
|
$210.42 B | $67.87 |
0.00%
|
-4.0%
|
United Kingdom
|
|
9
|
 Merck
MRK
|
$197.26 B | $78.39 |
-17.2%
|
-35.6%
|
United States
|
|
10
|
 Thermo Fisher Scientific
TMO
|
$166.47 B | $441.00 |
-15.4%
|
-19.2%
|
United States
|
|
11
|
 Amgen
AMGN
|
$158.77 B | $295.30 |
-7.3%
|
15.2%
|
United States
|
|
12
|
 Gilead Sciences
GILD
|
$131.74 B | $105.68 |
-4.1%
|
63.8%
|
United States
|
|
13
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B | $500.49 |
-2.3%
|
27.3%
|
United States
|
|
14
|
 Pfizer
PFE
|
$127.27 B | $22.44 |
-14.7%
|
-6.2%
|
United States
|
|
15
|
 Sanofi
SNY
|
$123.58 B | $50.60 |
0.00%
|
11.3%
|
France
|
|
16
|
 Bristol-Myers Squibb
BMY
|
$101.74 B | $50.00 |
-15.6%
|
9.7%
|
United States
|
|
17
|
 Chugai Pharmaceutical
4519.T
|
$77.71 B | $47.22 |
0.00%
|
32.5%
|
Japan
|
|
18
|
 CSL
CSL.AX
|
$74.32 B | $153.48 |
0.00%
|
-2.5%
|
Australia
|
|
19
|
 GlaxoSmithKline
GSK
|
$72.33 B | $35.68 |
0.00%
|
-16.6%
|
United Kingdom
|
|
20
|
 Zoetis
ZTS
|
$66.56 B | $149.22 |
-9.3%
|
-0.74%
|
United States
|
|
21
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B | $557.91 |
-16.1%
|
-38.0%
|
United States
|
|
22
|
 Samsung Biologics
207940.KS
|
$50.92 B | $715.49 |
0.00%
|
51.4%
|
South Korea
|
|
23
|
 Sun Pharmaceutical
SUNPHARMA.NS
|
$47.49 B | $19.79 |
0.00%
|
17.2%
|
India
|
|
24
|
 Lonza
LONN.SW
|
$47.44 B | $657.59 |
0.00%
|
14.2%
|
Switzerland
|
|
25
|
 Takeda Pharmaceutical
TAK
|
$45.76 B | $14.54 |
0.00%
|
-0.84%
|
Japan
|
|
26
|
 Jiangsu Hengrui Medicine
600276.SS
|
$43.18 B | $6.69 |
0.00%
|
0.22%
|
China
|
|
27
|
 Daiichi Sankyō
4568.T
|
$40.83 B | $21.85 |
0.00%
|
-6.7%
|
Japan
|
|
28
|
 Argenx
ARGX
|
$36.92 B | $605.38 |
0.00%
|
74.6%
|
Netherlands
|
|
29
|
 UCB
UCB.VI
|
$30.74 B | $158.75 |
0.00%
|
53.4%
|
Belgium
|
|
30
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B | $230.93 |
0.00%
|
88.6%
|
United States
|
|
31
|
 Agilent Technologies
A
|
$29.40 B | $103.12 |
0.00%
|
7.4%
|
United States
|
|
32
|
 Novozymes
NZYM.VI
|
$28.61 B | $61.42 |
0.00%
|
14.1%
|
Denmark
|
|
33
|
 Novonesis A/S
NSIS-B.CO
|
$28.60 B | $61.37 |
0.00%
|
7.3%
|
Denmark
|
|
34
|
 DexCom
DXCM
|
$27.15 B | $69.23 |
-2.1%
|
-48.3%
|
United States
|
|
35
|
 Otsuka Holdings
4578.T
|
$25.08 B | $47.36 |
0.00%
|
31.4%
|
Japan
|
|
36
|
 Celltrion
068270.KS
|
$24.23 B | $111.28 |
0.00%
|
11.1%
|
South Korea
|
|
37
|
 BioNTech
BNTX
|
$23.80 B | $99.00 |
0.00%
|
38.7%
|
Germany
|
|
38
|
 Bayer
BAYN.DE
|
$22.92 B | $23.33 |
0.00%
|
-18.2%
|
Germany
|
|
39
|
 BeiGene
BGNE
|
$20.21 B | $230.86 |
0.00%
|
66.6%
|
China
|
|
40
|
 LabCorp
LH
|
$18.91 B | $226.02 |
0.00%
|
23.8%
|
United States
|
|
41
|
 Royalty Pharma
RPRX
|
$18.64 B | $32.45 |
0.00%
|
11.3%
|
United Kingdom
|
|
42
|
 Summit Therapeutics
SMMT
|
$18.16 B | $24.62 |
0.00%
|
366.4%
|
United Kingdom
|
|
43
|
 Divis Laboratories
DIVISLAB.NS
|
$17.79 B | $67.01 |
0.00%
|
62.5%
|
India
|
|
44
|
 Sandoz Group
SDZ.SW
|
$17.25 B | $40.04 |
0.00%
|
54.6%
|
Switzerland
|
|
45
|
 Biogen
BIIB
|
$17.12 B | $116.98 |
0.00%
|
-25.8%
|
United States
|
|
46
|
 Hansoh Pharma
3692.HK
|
$16.72 B | $2.82 |
0.00%
|
16.8%
|
China
|
|
47
|
 Astellas Pharma
4503.T
|
$16.56 B | $9.25 |
0.00%
|
7.4%
|
Japan
|
|
48
|
 bioMérieux
BIM.PA
|
$15.68 B | $132.93 |
0.00%
|
8.6%
|
France
|
|
49
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B | $13.60 |
0.00%
|
23.3%
|
Israel
|
|
50
|
 Baxter
BAX
|
$14.26 B | $27.80 |
0.00%
|
-20.3%
|
United States
|
|
51
|
 Cipla
CIPLA.NS
|
$14.08 B | $17.43 |
0.00%
|
8.4%
|
India
|
|
52
|
 Intra-Cellular Therapies
ITCI
|
$14.05 B | $131.87 |
0.00%
|
65.8%
|
United States
|
|
53
|
 Shionogi
4507.T
|
$13.82 B | $16.24 |
0.00%
|
-1.0%
|
Japan
|
|
54
|
 Alteogen
196170.KQ
|
$13.66 B | $256.33 |
0.00%
|
145.6%
|
South Korea
|
|
55
|
 Insmed
INSM
|
$12.92 B | $71.07 |
0.00%
|
198.4%
|
United States
|
|
56
|
 United Therapeutics
UTHR
|
$12.79 B | $284.82 |
0.00%
|
46.9%
|
United States
|
|
57
|
 Torrent Pharmaceuticals
TORNTPHARM.NS
|
$12.70 B | $37.51 |
0.00%
|
28.0%
|
India
|
|
58
|
 Genmab A/S
GMAB.CO
|
$12.16 B | $194.25 |
0.00%
|
-24.5%
|
|
|
59
|
 Mankind Pharma
MANKIND.NS
|
$12.10 B | $29.30 |
0.00%
|
11.3%
|
India
|
|
60
|
 Genmab
GMAB
|
$11.92 B | $19.51 |
0.00%
|
-25.3%
|
Denmark
|
|
61
|
 Illumina
ILMN
|
$11.80 B | $74.59 |
0.00%
|
-8.8%
|
United States
|
|
62
|
 ICON plc
ICLR
|
$11.73 B | $145.16 |
0.00%
|
-36.2%
|
Ireland
|
|
63
|
 Catalent
CTLT
|
$11.52 B | $63.48 |
0.00%
|
13.4%
|
United States
|
|
64
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B | $60.02 |
0.00%
|
-29.8%
|
United States
|
|
65
|
 Revvity
RVTY
|
$11.48 B | $95.54 |
0.00%
|
14.5%
|
United States
|
|
66
|
 Incyte
INCY
|
$11.31 B | $58.46 |
0.00%
|
29.6%
|
United States
|
|
67
|
 Recordati
REC.MI
|
$11.14 B | $54.10 |
0.00%
|
24.9%
|
Italy
|
|
68
|
 Dr. Reddy's
RDY
|
$11.10 B | $13.32 |
0.00%
|
7.6%
|
India
|
|
69
|
 WuXi Biologics
WXXWY
|
$11.02 B | $5.41 |
0.00%
|
66.4%
|
China
|
|
70
|
 Lupin Limited
LUPIN.NS
|
$10.25 B | $22.46 |
0.00%
|
35.8%
|
India
|
|
71
|
 Exelixis
EXEL
|
$10.23 B | $36.54 |
0.00%
|
46.5%
|
United States
|
|
72
|
 Moderna
MRNA
|
$10.14 B | $26.24 |
-22.4%
|
-74.6%
|
United States
|
|
73
|
 Akeso
9926.HK
|
$9.68 B | $10.79 |
0.00%
|
36.3%
|
China
|
|
74
|
 Zydus Lifesciences
ZYDUSLIFE.NS
|
$9.58 B | $9.51 |
0.00%
|
7.0%
|
India
|
|
75
|
 Neurocrine Biosciences
NBIX
|
$9.51 B | $96.16 |
0.00%
|
-10.8%
|
United States
|
|
76
|
 Ascendis Pharma
ASND
|
$9.25 B | $153.92 |
0.00%
|
1.3%
|
Denmark
|
|
77
|
 Medpace
MEDP
|
$9.22 B | $305.00 |
0.00%
|
-7.3%
|
United States
|
|
78
|
 Swedish Orphan Biovitrum
SOBI.ST
|
$9.14 B | $26.63 |
0.00%
|
23.8%
|
Sweden
|
|
79
|
 Ipsen
IPN.PA
|
$9.02 B | $109.08 |
0.00%
|
12.4%
|
France
|
|
80
|
 Qiagen
QGEN
|
$8.98 B | $41.53 |
0.00%
|
1.6%
|
Netherlands
|
|
81
|
 Viatris
VTRS
|
$8.93 B | $7.48 |
0.00%
|
-1.4%
|
United States
|
|
82
|
 Cerevel Therapeutics
CERE
|
$8.19 B | $44.96 |
0.00%
|
8.1%
|
United States
|
|
83
|
 Exact Sciences
EXAS
|
$8.11 B | $43.67 |
0.00%
|
-17.1%
|
United States
|
|
84
|
 Bio-Techne
TECH
|
$8.07 B | $51.07 |
0.00%
|
11.8%
|
United States
|
|
85
|
 kyowa Kirin
4151.T
|
$8.06 B | $15.41 |
0.00%
|
-8.7%
|
Japan
|
|
86
|
 Orion Corporation
ORNAV.HE
|
$7.80 B | $55.35 |
0.00%
|
59.1%
|
Finland
|
|
87
|
 Verona Pharma
VRNA
|
$7.78 B | $58.47 |
0.00%
|
195.4%
|
United Kingdom
|
|
88
|
 Abbott India
ABBOTINDIA.NS
|
$7.68 B | $360.89 |
0.00%
|
9.9%
|
India
|
|
89
|
 Aurobindo Pharma
AUROPHARMA.NS
|
$7.63 B | $13.14 |
0.00%
|
5.4%
|
India
|
|
90
|
 Eisai
4523.T
|
$7.62 B | $27.03 |
0.00%
|
-26.8%
|
Japan
|
|
91
|
 Halozyme Therapeutics
HALO
|
$7.57 B | $61.28 |
0.00%
|
50.8%
|
United States
|
|
92
|
 Tempus AI
TEM
|
$7.43 B | $42.93 |
0.00%
|
69.8%
|
United States
|
|
93
|
 Corcept Therapeutics
CORT
|
$7.34 B | $69.59 |
0.00%
|
193.7%
|
United States
|
|
94
|
 Roivant Sciences
ROIV
|
$7.18 B | $10.06 |
0.00%
|
4.8%
|
United Kingdom
|
|
95
|
 Repligen
RGEN
|
$7.11 B | $126.62 |
0.00%
|
-4.4%
|
United States
|
|
96
|
 Madrigal Pharmaceuticals
MDGL
|
$7.09 B | $321.10 |
0.00%
|
47.8%
|
United States
|
|
97
|
 Lantheus Holdings
LNTH
|
$7.05 B | $102.78 |
0.00%
|
41.4%
|
United States
|
|
98
|
 Alkem Laboratories
ALKEM.NS
|
$6.91 B | $57.81 |
0.00%
|
13.3%
|
India
|
|
99
|
 Revolution Medicines
RVMD
|
$6.75 B | $36.32 |
0.00%
|
14.2%
|
United States
|
|
100
|
 BridgeBio Pharma
BBIO
|
$6.51 B | $34.24 |
0.00%
|
27.1%
|
United States
|
|
101
|
 Jazz Pharmaceuticals
JAZZ
|
$6.25 B | $102.91 |
0.00%
|
25.1%
|
Ireland
|
|
102
|
 Legend Biotech
LEGN
|
$6.20 B | $33.74 |
0.00%
|
-26.8%
|
United States
|
|
103
|
 TG Therapeutics
TGTX
|
$6.13 B | $39.03 |
0.00%
|
133.4%
|
United States
|
|
104
|
 Yuhan
000100.KS
|
$5.94 B | $79.38 |
0.00%
|
81.7%
|
South Korea
|
|
105
|
 DiaSorin
DIA.MI
|
$5.86 B | $108.83 |
0.00%
|
11.5%
|
Italy
|
|
106
|
 Grifols
GRFS
|
$5.71 B | $6.99 |
0.00%
|
11.2%
|
Spain
|
|
107
|
 Ono Pharmaceutical
4528.T
|
$5.63 B | $12.00 |
0.00%
|
-28.0%
|
Japan
|
|
108
|
 Telix Pharmaceuticals
TLX.AX
|
$5.50 B | $16.41 |
0.00%
|
117.2%
|
Australia
|
|
109
|
 Hikma Pharmaceuticals
HIK.L
|
$5.50 B | $2494.40 |
0.00%
|
14.6%
|
United Kingdom
|
|
110
|
 Glaukos
GKOS
|
$5.35 B | $94.52 |
0.00%
|
54.8%
|
United States
|
|
111
|
 Sarepta Therapeutics
SRPT
|
$5.28 B | $54.42 |
0.00%
|
-4.4%
|
United States
|
|
112
|
 ADMA Biologics
ADMA
|
$5.26 B | $22.15 |
0.00%
|
175.8%
|
United States
|
|
113
|
 Richter Gedeon
RIG2.F
|
$5.22 B | $28.62 |
0.00%
|
0.00%
|
|
|
114
|
 Blueprint Medicines
BPMC
|
$5.21 B | $81.45 |
0.00%
|
17.7%
|
United States
|
|
115
|
 Charles River Laboratories
CRL
|
$5.20 B | $105.92 |
0.00%
|
-30.5%
|
United States
|
|
116
|
 Nuvalent
NUVL
|
$5.07 B | $70.78 |
0.00%
|
29.7%
|
United States
|
|
117
|
 Axsome Therapeutics
AXSM
|
$5.06 B | $103.83 |
0.00%
|
82.3%
|
United States
|
|
118
|
 Galenica
GALE.SW
|
$5.04 B | $101.18 |
0.00%
|
18.2%
|
Switzerland
|
|
119
|
 ALK-Abelló
ALK-B.CO
|
$4.90 B | $22.11 |
0.00%
|
22.3%
|
Denmark
|
|
120
|
 Krystal Biotech
KRYS
|
$4.89 B | $169.13 |
0.00%
|
-8.9%
|
United States
|
|
121
|
 Siegfried Holding
SFZN.SW
|
$4.74 B | $1082.55 |
0.00%
|
13.4%
|
Switzerland
|
|
122
|
 Zealand Pharma
ZEAL.CO
|
$4.69 B | $66.34 |
0.00%
|
29.1%
|
Denmark
|
|
123
|
 Biocon
BIOCON.NS
|
$4.61 B | $3.84 |
0.00%
|
45.3%
|
India
|
|
124
|
 Alkermes
ALKS
|
$4.61 B | $27.94 |
0.00%
|
49.5%
|
Ireland
|
|
125
|
 Cytokinetics
CYTK
|
$4.60 B | $38.56 |
0.00%
|
-37.9%
|
United States
|
|
126
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B | $28.38 |
0.00%
|
-23.1%
|
United States
|
|
127
|
 Glenmark Pharmaceuticals
GLENMARK.NS
|
$4.46 B | $15.81 |
0.00%
|
45.7%
|
India
|
|
128
|
 Bachem
BANB.SW
|
$4.36 B | $58.22 |
0.00%
|
-27.4%
|
Switzerland
|
|
129
|
 H. Lundbeck A/S
HLUN-A.CO
|
$4.17 B | $3.70 |
0.00%
|
21.4%
|
Denmark
|
|
130
|
 Lundbeck
HLUN-B.CO
|
$4.15 B | $4.32 |
0.00%
|
28.3%
|
Denmark
|
|
131
|
 Ipca Laboratories
IPCALAB.NS
|
$4.12 B | $16.22 |
0.00%
|
17.8%
|
India
|
|
132
|
 Elanco
ELAN
|
$4.09 B | $8.24 |
0.00%
|
-14.4%
|
United States
|
|
133
|
 Hualan Biological Engineering
002007.SZ
|
$4.07 B | $2.21 |
0.00%
|
-12.6%
|
China
|
|
134
|
 Laurus Labs
LAURUSLABS.NS
|
$3.94 B | $7.30 |
0.00%
|
31.9%
|
India
|
|
135
|
 China Resources Pharmaceutical Group
3320.HK
|
$3.93 B | $0.63 |
0.00%
|
18.9%
|
Hong Kong
|
|
136
|
 Rhythm Pharmaceuticals
RYTM
|
$3.93 B | $62.09 |
0.00%
|
52.1%
|
United States
|
|
137
|
 Vaxcyte
PCVX
|
$3.89 B | $30.23 |
0.00%
|
37.7%
|
United States
|
|
138
|
 Rohto Pharmaceutical
4527.T
|
$3.77 B | $16.41 |
0.00%
|
-5.0%
|
Japan
|
|
139
|
 PTC Therapeutics
PTCT
|
$3.70 B | $46.94 |
0.00%
|
98.0%
|
United States
|
|
140
|
 Perrigo
PRGO
|
$3.42 B | $25.06 |
0.00%
|
-16.9%
|
Ireland
|
|
141
|
 Piramal Pharma
PPLPHARMA.NS
|
$3.42 B | $2.59 |
0.00%
|
65.8%
|
India
|
|
142
|
 Arcellx
ACLX
|
$3.38 B | $61.43 |
0.00%
|
25.1%
|
United States
|
|
143
|
 CRISPR Therapeutics
CRSP
|
$3.34 B | $38.95 |
0.00%
|
-10.5%
|
Switzerland
|
|
144
|
 Amneal Pharmaceuticals
AMRX
|
$3.34 B | $7.17 |
0.00%
|
45.6%
|
United States
|
|
145
|
 Zai Lab
ZLAB
|
$3.33 B | $30.38 |
0.00%
|
99.9%
|
China
|
|
146
|
 Santen Pharmaceutical
4536.T
|
$3.33 B | $9.75 |
0.00%
|
8.6%
|
Japan
|
|
147
|
 Ultragenyx
RARE
|
$3.32 B | $35.34 |
0.00%
|
1.5%
|
United States
|
|
148
|
 Olink Holding
OLK
|
$3.24 B | $26.08 |
0.00%
|
17.0%
|
Sweden
|
|
149
|
 Soleno Therapeutics
SLNO
|
$3.22 B | $70.25 |
0.00%
|
32.5%
|
United States
|
|
150
|
 Avidity Biosciences
RNA
|
$3.21 B | $26.68 |
0.00%
|
45.7%
|
United States
|
|
151
|
 Sinopharm
1099.HK
|
$3.04 B | $2.27 |
0.00%
|
5.1%
|
China
|
|
152
|
 Akero Therapeutics
AKRO
|
$3.03 B | $38.08 |
0.00%
|
136.8%
|
United States
|
|
153
|
 Merus
MRUS
|
$2.99 B | $43.22 |
0.00%
|
-2.1%
|
Netherlands
|
|
154
|
 Genscript Biotech
1548.HK
|
$2.92 B | $1.35 |
0.00%
|
-7.3%
|
China
|
|
155
|
 Jamjoom Pharmaceuticals Factory Company
4015.SR
|
$2.91 B | $41.61 |
0.00%
|
32.8%
|
Saudi Arabia
|
|
156
|
 Laboratorios Farmaceuticos Rovi
ROVI.MC
|
$2.88 B | $56.36 |
0.00%
|
-32.0%
|
Spain
|
|
157
|
 Protagonist Therapeutics
PTGX
|
$2.88 B | $46.95 |
0.00%
|
48.6%
|
United States
|
|
158
|
 GeneDx Holdings
WGS
|
$2.87 B | $102.22 |
0.00%
|
640.8%
|
United States
|
|
159
|
 Scholar Rock Holding
SRRK
|
$2.87 B | $30.22 |
0.00%
|
178.4%
|
United States
|
|
160
|
 Morphic Therapeutic
MORF
|
$2.86 B | $56.99 |
0.00%
|
104.5%
|
United States
|
|
161
|
 Morphosys
MOR
|
$2.86 B | $18.96 |
0.00%
|
5.1%
|
Germany
|
|
162
|
 Organon
OGN
|
$2.85 B | $11.05 |
0.00%
|
-11.9%
|
United States
|
|
163
|
 KOBAYASHI Pharmaceutical
4967.T
|
$2.84 B | $38.19 |
0.00%
|
5.1%
|
Japan
|
|
164
|
 Virbac SA
VIRP.PA
|
$2.83 B | $338.31 |
0.00%
|
-13.4%
|
France
|
|
165
|
 Catalyst Pharmaceuticals
CPRX
|
$2.83 B | $23.23 |
0.00%
|
42.3%
|
United States
|
|
166
|
 SpringWorks Therapeutics
SWTX
|
$2.82 B | $37.59 |
0.00%
|
22.4%
|
United States
|
|
167
|
 Gland Pharma
GLAND.NS
|
$2.78 B | $16.87 |
0.00%
|
-4.4%
|
India
|
|
168
|
 Crinetics Pharmaceuticals
CRNX
|
$2.76 B | $29.66 |
0.00%
|
-17.0%
|
United States
|
|
169
|
 Immunovant
IMVT
|
$2.63 B | $15.47 |
0.00%
|
-31.3%
|
United States
|
|
170
|
 Alvotech
ALVO
|
$2.60 B | $8.60 |
0.00%
|
1.5%
|
Iceland
|
|
171
|
 Viking Therapeutics
VKTX
|
$2.59 B | $23.11 |
0.00%
|
-54.6%
|
United States
|
|
172
|
 WuXi AppTec
2359.HK
|
$2.55 B | $6.59 |
0.00%
|
76.0%
|
China
|
|
173
|
 Xenon Pharmaceuticals
XENE
|
$2.53 B | $33.03 |
0.00%
|
-6.5%
|
Canada
|
|
174
|
 ACADIA Pharmaceuticals
ACAD
|
$2.50 B | $14.99 |
0.00%
|
9.8%
|
United States
|
|
175
|
 HUTCHMED
HCM
|
$2.46 B | $14.38 |
0.00%
|
-16.1%
|
Hong Kong
|
|
176
|
 ImmunityBio
IBRX
|
$2.45 B | $2.78 |
0.00%
|
-35.3%
|
United States
|
|
177
|
 Apellis Pharmaceuticals
APLS
|
$2.38 B | $18.97 |
0.00%
|
-40.3%
|
United States
|
|
178
|
 Twist Bioscience
TWST
|
$2.36 B | $39.50 |
0.00%
|
70.2%
|
United States
|
|
179
|
 Longboard Pharmaceuticals
LBPH
|
$2.34 B | $59.98 |
0.00%
|
252.8%
|
United States
|
|
180
|
 MoonLake Immunotherapeutics
MLTX
|
$2.33 B | $36.77 |
0.00%
|
-0.69%
|
Switzerland
|
|
181
|
 Tecan
TECN.SW
|
$2.27 B | $176.97 |
0.00%
|
-35.2%
|
Switzerland
|
|
182
|
 Recursion Pharmaceuticals
RXRX
|
$2.27 B | $5.64 |
0.00%
|
2.4%
|
United States
|
|
183
|
 Almirall
ALM.MC
|
$2.26 B | $10.58 |
0.00%
|
15.2%
|
Spain
|
|
184
|
 Certara
CERT
|
$2.24 B | $13.88 |
0.00%
|
-17.4%
|
United States
|
|
185
|
 Amicus Therapeutics
FOLD
|
$2.12 B | $6.90 |
0.00%
|
-8.6%
|
United States
|
|
186
|
 Vericel
VCEL
|
$2.11 B | $42.01 |
0.00%
|
26.8%
|
United States
|
|
187
|
 Tarsus Pharmaceuticals
TARS
|
$2.04 B | $49.12 |
0.00%
|
50.4%
|
United States
|
|
188
|
 Alembic Pharmaceuticals
APLLTD.NS
|
$1.97 B | $10.00 |
0.00%
|
9.6%
|
India
|
|
189
|
 Apogee Therapeutics
APGE
|
$1.91 B | $32.85 |
0.00%
|
-23.6%
|
United States
|
|
190
|
 Neuland Laboratories
NEULANDLAB.NS
|
$1.91 B | $148.56 |
0.00%
|
74.0%
|
India
|
|
191
|
 Belite Bio
BLTE
|
$1.90 B | $58.88 |
0.00%
|
66.4%
|
United States
|
|
192
|
 Biohaven Pharmaceutical
BHVN
|
$1.89 B | $18.56 |
0.00%
|
-13.1%
|
United States
|
|
193
|
 Mirum Pharmaceuticals
MIRM
|
$1.89 B | $38.63 |
0.00%
|
111.6%
|
United States
|
|
194
|
 Fusion Pharmaceuticals
FUSN
|
$1.83 B | $21.55 |
0.00%
|
0.00%
|
Canada
|
|
195
|
 Novocure
NVCR
|
$1.81 B | $16.46 |
0.00%
|
86.6%
|
|
|
196
|
 BB Biotech
BION.SW
|
$1.78 B | $32.46 |
0.00%
|
-9.9%
|
Switzerland
|
|
197
|
 Bavarian Nordic
BAVA.CO
|
$1.78 B | $22.85 |
0.00%
|
18.7%
|
Denmark
|
|
198
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.77 B | $12.87 |
0.00%
|
-11.6%
|
United States
|
|
199
|
 NewAmsterdam Pharma Company
NAMS
|
$1.76 B | $16.06 |
0.00%
|
-0.70%
|
Netherlands
|
|
200
|
 Supernus Pharmaceuticals
SUPN
|
$1.76 B | $31.46 |
0.00%
|
30.8%
|
United States
|